Literature DB >> 22411434

Diabetes: FFAR1 activation improves glycemia.

Linda Koch.   

Abstract

Entities:  

Year:  2012        PMID： 22411434     DOI： 10.1038/nrendo.2012.35

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.

Authors:  Charles F Burant; Prabhakar Viswanathan; John Marcinak; Charlie Cao; Majid Vakilynejad; Benhuai Xie; Eckhard Leifke
Journal:  Lancet       Date:  2012-02-27       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.